David Pozo Pérez-rekin lankidetzan egindako argitalpenak (8)

2000

  1. Immunobiology of vasoactive intestinal peptide (VIP)

    Immunology Today

1999

  1. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase- activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6

    Journal of Immunology, Vol. 162, Núm. 2, pp. 1200-1205

  2. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: In vitro and in vivo studies

    Journal of Immunology, Vol. 162, Núm. 4, pp. 2358-2367

1998

  1. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: In vitro and in vivo studies

    Journal of Neuroimmunology, Vol. 85, Núm. 2, pp. 155-167

  2. Vasoactive intestinal peptide and pituitary adenylate cyclase- activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages

    Journal of Leukocyte Biology, Vol. 63, Núm. 5, pp. 591-601

1997

  1. Expression of the Mel(1a)-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen

    FASEB Journal, Vol. 11, Núm. 6, pp. 466-473

  2. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1359, Núm. 3, pp. 250-262

1996

  1. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages

    Regulatory Peptides, Vol. 62, Núm. 2-3, pp. 161-166